Published in Am J Pathol on June 01, 2000
Adipocyte lineage cells contribute to the skin stem cell niche to drive hair cycling. Cell (2011) 3.68
Biochemical and physiological function of stearoyl-CoA desaturase. Am J Physiol Endocrinol Metab (2008) 2.28
Hair follicle stem cell-specific PPARgamma deletion causes scarring alopecia. J Invest Dermatol (2008) 2.23
Role of stearoyl-coenzyme A desaturase in regulating lipid metabolism. Curr Opin Lipidol (2008) 2.22
Exploring the elephant: histopathology in high-throughput phenotyping of mutant mice. Dis Model Mech (2011) 1.62
A toll-like receptor 2-responsive lipid effector pathway protects mammals against skin infections with gram-positive bacteria. Infect Immun (2005) 1.55
Keratin 17 null mice exhibit age- and strain-dependent alopecia. Genes Dev (2002) 1.47
Skin-specific deletion of stearoyl-CoA desaturase-1 alters skin lipid composition and protects mice from high fat diet-induced obesity. J Biol Chem (2009) 1.31
Stearoyl-CoA desaturase-2 gene expression is required for lipid synthesis during early skin and liver development. Proc Natl Acad Sci U S A (2005) 1.31
Despite antiatherogenic metabolic characteristics, SCD1-deficient mice have increased inflammation and atherosclerosis. Arterioscler Thromb Vasc Biol (2008) 1.29
Mutations in sterol O-acyltransferase 1 (Soat1) result in hair interior defects in AKR/J mice. J Invest Dermatol (2010) 1.15
The lysosomal protease cathepsin L is an important regulator of keratinocyte and melanocyte differentiation during hair follicle morphogenesis and cycling. Am J Pathol (2002) 1.11
Retinoid metabolism is altered in human and mouse cicatricial alopecia. J Invest Dermatol (2012) 1.10
Absence of stearoyl-CoA desaturase-1 ameliorates features of the metabolic syndrome in LDLR-deficient mice. J Lipid Res (2007) 1.09
What color is the skin of a mouse? Vet Pathol (2011) 1.00
c-MYC-induced sebaceous gland differentiation is controlled by an androgen receptor/p53 axis. Cell Rep (2013) 0.97
Stearoyl-coenzyme A desaturase 1 inhibition and the metabolic syndrome: considerations for future drug discovery. Curr Opin Lipidol (2010) 0.96
Combined therapy of dietary fish oil and stearoyl-CoA desaturase 1 inhibition prevents the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol (2009) 0.94
Role of stearoyl-CoA desaturase-1 in skin integrity and whole body energy balance. J Biol Chem (2013) 0.92
Metabolic changes in skin caused by Scd1 deficiency: a focus on retinol metabolism. PLoS One (2011) 0.89
Normal fur development and sebum production depends on fatty acid 2-hydroxylase expression in sebaceous glands. J Biol Chem (2011) 0.88
Ulcerative dermatitis in C57BL/6 mice lacking stearoyl CoA desaturase 1. Comp Med (2012) 0.86
Endogenous retinoids in the hair follicle and sebaceous gland. Biochim Biophys Acta (2011) 0.85
Stem cells in ectodermal development. J Mol Med (Berl) (2012) 0.84
Mouse models for human hair loss disorders. J Anat (2003) 0.83
Differentiation of the sebaceous gland. Dermatoendocrinol (2009) 0.82
Characterization of hair follicle development in engineered skin substitutes. PLoS One (2013) 0.81
Absence of stearoyl-CoA desaturase-1 does not promote DSS-induced acute colitis. Biochim Biophys Acta (2009) 0.81
Does prostaglandin D2 hold the cure to male pattern baldness? Exp Dermatol (2014) 0.81
Scd1ab-Xyk: a new asebia allele characterized by a CCC trinucleotide insertion in exon 5 of the stearoyl-CoA desaturase 1 gene in mouse. Mol Genet Genomics (2004) 0.80
Pharmacological stimulation of Edar signaling in the adult enhances sebaceous gland size and function. J Invest Dermatol (2014) 0.79
Lipids to the top of hair biology. J Invest Dermatol (2010) 0.78
Murine vibrissae cultured in serum-free medium reinitiate anagen. J Invest Dermatol (2007) 0.78
The role of fatty acid desaturases in epidermal metabolism. Dermatoendocrinol (2011) 0.77
The Gustatory Signaling Pathway and Bitter Taste Receptors Affect the Development of Obesity and Adipocyte Metabolism in Mice. PLoS One (2015) 0.77
Retinal Pigment Epithelium Atrophy 1 (rpea1): A New Mouse Model With Retinal Detachment Caused by a Disruption of Protein Kinase C, θ. Invest Ophthalmol Vis Sci (2016) 0.76
The metabolic phenotype of SCD1-deficient mice is independent of melanin-concentrating hormone. Peptides (2009) 0.76
Mutations in LPAR6/P2RY5 and LIPH are associated with woolly hair and/or hypotrichosis. J Eur Acad Dermatol Venereol (2012) 0.76
Sebaceous gland, hair shaft, and epidermal barrier abnormalities in keratosis pilaris with and without filaggrin deficiency. Am J Pathol (2015) 0.75
Sebaceous Gland Atrophy in Psoriasis: An Explanation for Psoriatic Alopecia? J Invest Dermatol (2016) 0.75
Hair Follicle and Sebaceous Gland De Novo Regeneration With Cultured Epidermal Stem Cells and Skin-Derived Precursors. Stem Cells Transl Med (2016) 0.75
DHEA and frontal fibrosing alopecia: molecular and physiopathological mechanisms. An Bras Dermatol (2017) 0.75
Changes in the skin in relation to the hair growth cycle. Anat Rec (1953) 2.13
Scd1 is expressed in sebaceous glands and is disrupted in the asebia mouse. Nat Genet (1999) 1.84
A spontaneous mutation characterized by chronic proliferative dermatitis in C57BL mice. Am J Pathol (1993) 1.58
The influence of the hair cycle on the thickness of mouse skin. Anat Rec (1984) 1.35
Angora mouse mutation: altered hair cycle, follicular dystrophy, phenotypic maintenance of skin grafts, and changes in keratin expression. Vet Pathol (1997) 1.21
A hypothesis on the cause of chronic epidermal hyperproliferation in asebia mice. Clin Exp Dermatol (1988) 1.12
Skin lipids of a normal and mutant (asebic) mouse strain. J Invest Dermatol (1966) 1.04
Sodium lauryl sulphate for irritant patch testing--a dose-response study using bioengineering methods for determination of skin irritation. J Invest Dermatol (1990) 1.03
Lanceolate hair-J (lahJ): a mouse model for human hair disorders. Exp Dermatol (2000) 0.95
Cyclosporin inhibits intercellular adhesion molecule-1 expression and reduces mast cell numbers in the asebia mouse model of chronic skin inflammation. Br J Dermatol (1997) 0.94
Hereditary Absence of Sebaceous Glands in the Mouse. Science (1965) 0.92
Development and progression of psoriasiform dermatitis and systemic lesions in the flaky skin (fsn) mouse mutant. Pathobiology (1997) 0.90
Harlequin ichthyosis (ichq): a juvenile lethal mouse mutation with ichthyosiform dermatitis. Am J Pathol (1997) 0.90
The expression of the gene asebia in the laboratory mouse. I. Epidermis and dermis. Genet Res (1978) 0.87
Mechanisms of skin irritations. Curr Probl Dermatol (1995) 0.85
Formation and breakdown of the inner root sheath and features of the pilary canal epithelium in the wool follicle. J Ultrastruct Res (1971) 0.85
Transepidermal water loss in patients with dermatitis. Br J Dermatol (1969) 0.84
Transection level dictates the pattern of hair follicle sheath growth in vitro. Dev Biol (1994) 0.84
13-cis-Retinoic acid affect sheath-shaft interaction of equine hair follicles in vitro. J Invest Dermatol (1996) 0.83
The site of action of the asebia locus (ab) in the skin of the mouse. Genet Res (1986) 0.82
Mast cells in asebia mouse skin. J Invest Dermatol (1989) 0.82
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet (2001) 4.55
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain (1997) 3.87
250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study. Lancet Neurol (2009) 3.37
Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler (2008) 3.28
The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2003) 3.21
Construction of a uniform-abundance (normalized) cDNA library. Proc Natl Acad Sci U S A (1991) 3.12
White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging. J Neurol Neurosurg Psychiatry (2002) 2.72
Production of cloned pigs from in vitro systems. Nat Biotechnol (2000) 2.15
Pattern of brain tissue loss associated with freezing of gait in Parkinson disease. Neurology (2012) 2.13
Default-mode network dysfunction and cognitive impairment in progressive MS. Neurology (2010) 2.03
Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology (2003) 1.94
MRI criteria for MS in patients with clinically isolated syndromes. Neurology (2010) 1.90
Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis. AJNR Am J Neuroradiol (2000) 1.88
Reversible silencing of enhancers by sequences derived from the human IFN-alpha promoter. Cell (1987) 1.87
Scd1 is expressed in sebaceous glands and is disrupted in the asebia mouse. Nat Genet (1999) 1.84
Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment. Mult Scler (2005) 1.81
Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis. Neurology (2008) 1.80
Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis. Neurology (2008) 1.76
Human stearoyl-CoA desaturase: alternative transcripts generated from a single gene by usage of tandem polyadenylation sites. Biochem J (1999) 1.75
Correlation of multiple sclerosis measures derived from T2-weighted, T1-weighted, magnetization transfer, and diffusion tensor MR imaging. AJNR Am J Neuroradiol (2001) 1.75
The contribution of voxel-based morphometry in staging patients with mild cognitive impairment. Neurology (2006) 1.72
Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study. Mult Scler (2008) 1.70
Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directions. Arch Neurol (2005) 1.69
Loss of normal profilaggrin and filaggrin in flaky tail (ft/ft) mice: an animal model for the filaggrin-deficient skin disease ichthyosis vulgaris. J Invest Dermatol (2000) 1.69
A method for obtaining tract-specific diffusion tensor MRI measurements in the presence of disease: application to patients with clinically isolated syndromes suggestive of multiple sclerosis. Neuroimage (2005) 1.68
Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol (2000) 1.66
Molecular basis of hair growth control. J Invest Dermatol (1996) 1.65
A diffusion tensor MRI study of cervical cord damage in benign and secondary progressive multiple sclerosis patients. J Neurol Neurosurg Psychiatry (2009) 1.64
Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI study. Eur J Neurol (2008) 1.63
Evidence of thalamic gray matter loss in pediatric multiple sclerosis. Neurology (2008) 1.63
Randomized, double-blind, dose-comparison study of glatiramer acetate in relapsing-remitting MS. Neurology (2007) 1.62
Regional patterns of brain tissue loss associated with depression in Parkinson disease. Neurology (2010) 1.58
Voxelwise assessment of the regional distribution of damage in the brains of patients with multiple sclerosis and fatigue. AJNR Am J Neuroradiol (2011) 1.58
Spatial mapping of T2 and gadolinium-enhancing T1 lesion volumes in multiple sclerosis: evidence for distinct mechanisms of lesion genesis? Brain (1999) 1.56
Comparison of three MR sequences for the detection of cervical cord lesions in patients with multiple sclerosis. AJNR Am J Neuroradiol (1999) 1.54
Magnetic resonance imaging, magnetisation transfer imaging, and diffusion weighted imaging correlates of optic nerve, brain, and cervical cord damage in Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiatry (2001) 1.51
Diffusion MRI in multiple sclerosis. Neurology (2005) 1.49
In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study. Brain (2007) 1.48
Global N-acetylaspartate declines even in benign multiple sclerosis. AJNR Am J Neuroradiol (2010) 1.47
Experimental induction of alopecia areata-like hair loss in C3H/HeJ mice using full-thickness skin grafts. J Invest Dermatol (1998) 1.46
Relative contributions of brain and cervical cord pathology to multiple sclerosis disability: a study with magnetisation transfer ratio histogram analysis. J Neurol Neurosurg Psychiatry (2000) 1.43
Abnormal cervical cord function contributes to fatigue in multiple sclerosis. Mult Scler (2012) 1.42
The "mirror-neuron system" in MS: A 3 tesla fMRI study. Neurology (2007) 1.42
Magnetic resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosis. J Neurol (2003) 1.41
Failure of topical estrogen receptor agonists and antagonists to alter murine hair follicle cycling. J Invest Dermatol (1998) 1.40
Cladribine and progressive MS: clinical and MRI outcomes of a multicenter controlled trial. Cladribine MRI Study Group. Neurology (2000) 1.39
Scd3--a novel gene of the stearoyl-CoA desaturase family with restricted expression in skin. Genomics (2001) 1.38
Effects of seasons on magnetic resonance imaging--measured disease activity in patients with multiple sclerosis. Ann Neurol (2001) 1.35
Cortical lesions in primary progressive multiple sclerosis: a 2-year longitudinal MR study. Neurology (2009) 1.35
Identification of seven new human MHC class I region genes around the HLA-F locus. Immunogenetics (1996) 1.34
Primary follicular dystrophy with scarring dermatitis in C57BL/6 mouse substrains resembles central centrifugal cicatricial alopecia in humans. Vet Pathol (2010) 1.32
The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis. Neurology (1999) 1.31
The present and the future of neuroimaging in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol (2010) 1.30
MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability. Neurology (2006) 1.29
Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes. Neurology (2010) 1.27
Influence of aging on brain gray and white matter changes assessed by conventional, MT, and DT MRI. Neurology (2006) 1.26
Voxel-based morphometry study of brain volumetry and diffusivity in amyotrophic lateral sclerosis patients with mild disability. Hum Brain Mapp (2007) 1.25
Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosis. Ann Neurol (2004) 1.25
Identification of a new human catenin gene family member (ARVCF) from the region deleted in velo-cardio-facial syndrome. Genomics (1997) 1.24
Alopecia areata investigational assessment guidelines. National Alopecia Areata Foundation. J Am Acad Dermatol (1999) 1.24
Pearls & Oy-sters: The medial longitudinal fasciculus in ocular motor physiology. Neurology (2008) 1.24
Absence of Peyer's patches and abnormal lymphoid architecture in chronic proliferative dermatitis (cpdm/cpdm) mice. J Immunol (1999) 1.23
Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates. Brain (1999) 1.22
Angora mouse mutation: altered hair cycle, follicular dystrophy, phenotypic maintenance of skin grafts, and changes in keratin expression. Vet Pathol (1997) 1.21
Restless legs syndrome is a common finding in multiple sclerosis and correlates with cervical cord damage. Mult Scler (2007) 1.21
A multicenter assessment of cervical cord atrophy among MS clinical phenotypes. Neurology (2011) 1.20
Correlates of MS disability assessed in vivo using aggregates of MR quantities. Neurology (2001) 1.20
Modelling MRI enhancing lesion counts in multiple sclerosis using a negative binomial model: implications for clinical trials. J Neurol Sci (1999) 1.20
Hair follicle growth controls. Dermatol Clin (1996) 1.19
In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis. Brain (2001) 1.17
Follow-up of interhemispheric differences of motor evoked potentials from the 'affected' and 'unaffected' hemispheres in human stroke. Brain Res (1998) 1.16
Assessment of white matter tract damage in patients with amyotrophic lateral sclerosis: a diffusion tensor MR imaging tractography study. AJNR Am J Neuroradiol (2010) 1.16
Mean diffusivity and fractional anisotropy histograms of patients with multiple sclerosis. AJNR Am J Neuroradiol (2001) 1.16
Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis. Neurology (1998) 1.15
Construction and characterization of a bovine BAC library with four genome-equivalent coverage. Genet Sel Evol (2001) 1.14
Comparison of alopecia areata in human and nonhuman mammalian species. Pathobiology (1998) 1.14
The current state-of-the-art of spinal cord imaging: applications. Neuroimage (2013) 1.13
The current state-of-the-art of spinal cord imaging: methods. Neuroimage (2013) 1.12
Increased expression of type 2 cytokines in chronic proliferative dermatitis (cpdm) mutant mice and resolution of inflammation following treatment with IL-12. Eur J Immunol (2001) 1.12
Primary angiitis of the central nervous system: serial MRI of brain and spinal cord. Neuroradiology (2001) 1.12
Nocturnal sleep study in multiple sclerosis: correlations with clinical and brain magnetic resonance imaging findings. J Neurol Sci (1994) 1.12
Quantification of tissue damage in AD using diffusion tensor and magnetization transfer MRI. Neurology (2001) 1.11
Intra-observer reproducibility in measuring new putative MR markers of demyelination and axonal loss in multiple sclerosis: a comparison with conventional T2-weighted images. J Neurol (1997) 1.10
Specimen damage caused by the beam of the transmission electron microscope, a correlative reconsideration. J Ultrastruct Res (1970) 1.10
White matter damage in frontotemporal lobar degeneration spectrum. Cereb Cortex (2011) 1.10
Measurement error of two different techniques for brain atrophy assessment in multiple sclerosis. Neurology (2004) 1.09
Altered functional and structural connectivities in patients with MS: a 3-T study. Neurology (2007) 1.09
Short-term brain volume change in relapsing-remitting multiple sclerosis: effect of glatiramer acetate and implications. Brain (2001) 1.08
High prevalence of restless legs syndrome in multiple sclerosis. Eur J Neurol (2007) 1.08
[Laparoscopic or open appendectomy. Critical review of the literature and personal experience]. G Chir (2001) 1.08
Role of white matter lesions in cognitive impairment of vascular origin. Alzheimer Dis Assoc Disord (2000) 1.08
Functional basis of memory impairment in multiple sclerosis: a[18F]FDG PET study. Neuroimage (1996) 1.08